NASDAQ
No price data available for this timeframe.
Nurix Therapeutics, Inc. (NRIX) has a free cash flow growth of 0.01% as of Friday, May 29, 2026. This represents a 100.05% increase compared to its 12-month average of -10.40%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.